Latest Securities Issuance News

ColCap Financial Limited (ASX:TT6) reported a 16% rise in net profit to $72.2 million for FY2025, driven by a 15% expansion in its loan portfolio to $19.3 billion and a series of record Residential Mortgage-Backed Securities issuances.

African Gold Ltd has finalised its court-approved scheme of arrangement, transferring all shares and options to Montage Gold Corp and preparing for imminent ASX delisting.

NT Minerals Limited aims to raise up to $968,722 through a pro-rata entitlement offer and complete the acquisition of Slipstream Paynes Find, a move critical to meeting ASX reinstatement conditions and funding exploration in Western Australia.

Wisr Limited reports robust half-year growth with a 23% increase in its loan book and a 14% rise in revenue, setting the stage for expected cash profitability in the second half of FY26.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

AuMEGA Metals has launched a C$10 million private placement to fund an extensive drilling program targeting high-potential gold and base metal prospects in Newfoundland’s Cape Ray District. The financing aims to unlock value from its significant mineral resources and strategic landholdings.

Askari Metals has addressed an ASX query regarding the late filing of a director's securities interest notice, attributing the delay to awaiting regulatory guidance following an inadvertent related party securities breach.

BOA Resources has completed the issuance of securities tied to its $3.75 million placement after securing shareholder approval earlier this month.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

Conico Ltd has raised $2.8 million through a share placement and entitlement offer, appointing Guy Le Page as Executive Chairman to steer its next exploration phase.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.